| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | extracellular matrix structural constituent | 7.52e-08 | 188 | 24 | 6 | GO:0005201 | |
| GeneOntologyMolecularFunction | BMP receptor binding | 1.07e-04 | 13 | 24 | 2 | GO:0070700 | |
| GeneOntologyMolecularFunction | semaphorin receptor binding | 3.45e-04 | 23 | 24 | 2 | GO:0030215 | |
| GeneOntologyMolecularFunction | transmembrane receptor protein serine/threonine kinase binding | 4.77e-04 | 27 | 24 | 2 | GO:0070696 | |
| GeneOntologyMolecularFunction | structural molecule activity | 5.23e-04 | 891 | 24 | 6 | GO:0005198 | |
| GeneOntologyMolecularFunction | chemorepellent activity | 5.51e-04 | 29 | 24 | 2 | GO:0045499 | |
| GeneOntologyMolecularFunction | receptor serine/threonine kinase binding | 8.04e-04 | 35 | 24 | 2 | GO:0033612 | |
| GeneOntologyMolecularFunction | proteoglycan binding | 1.70e-03 | 51 | 24 | 2 | GO:0043394 | |
| GeneOntologyMolecularFunction | phosphatidylserine binding | 3.45e-03 | 73 | 24 | 2 | GO:0001786 | |
| GeneOntologyMolecularFunction | glycosaminoglycan binding | 3.93e-03 | 268 | 24 | 3 | GO:0005539 | |
| GeneOntologyMolecularFunction | sulfur compound binding | 6.60e-03 | 323 | 24 | 3 | GO:1901681 | |
| GeneOntologyMolecularFunction | modified amino acid binding | 9.36e-03 | 122 | 24 | 2 | GO:0072341 | |
| GeneOntologyMolecularFunction | calcium ion binding | 1.15e-02 | 749 | 24 | 4 | GO:0005509 | |
| GeneOntologyBiologicalProcess | extracellular matrix organization | 3.65e-06 | 377 | 24 | 6 | GO:0030198 | |
| GeneOntologyBiologicalProcess | extracellular structure organization | 3.71e-06 | 378 | 24 | 6 | GO:0043062 | |
| GeneOntologyBiologicalProcess | external encapsulating structure organization | 3.76e-06 | 379 | 24 | 6 | GO:0045229 | |
| GeneOntologyBiologicalProcess | positive regulation of transmembrane receptor protein serine/threonine kinase signaling pathway | 8.94e-06 | 115 | 24 | 4 | GO:0090100 | |
| GeneOntologyBiologicalProcess | cell-matrix adhesion | 1.28e-05 | 270 | 24 | 5 | GO:0007160 | |
| GeneOntologyBiologicalProcess | cell-substrate adhesion | 9.42e-05 | 410 | 24 | 5 | GO:0031589 | |
| GeneOntologyBiologicalProcess | cell-cell fusion | 1.28e-04 | 85 | 24 | 3 | GO:0140253 | |
| GeneOntologyBiologicalProcess | syncytium formation by plasma membrane fusion | 1.28e-04 | 85 | 24 | 3 | GO:0000768 | |
| GeneOntologyBiologicalProcess | engulfment of apoptotic cell | 1.35e-04 | 15 | 24 | 2 | GO:0043652 | |
| GeneOntologyBiologicalProcess | syncytium formation | 1.47e-04 | 89 | 24 | 3 | GO:0006949 | |
| GeneOntologyBiologicalProcess | tube morphogenesis | 2.15e-04 | 1125 | 24 | 7 | GO:0035239 | |
| GeneOntologyBiologicalProcess | positive regulation of myoblast fusion | 2.19e-04 | 19 | 24 | 2 | GO:1901741 | |
| GeneOntologyBiologicalProcess | detection of light stimulus involved in visual perception | 3.83e-04 | 25 | 24 | 2 | GO:0050908 | |
| GeneOntologyBiologicalProcess | detection of light stimulus involved in sensory perception | 3.83e-04 | 25 | 24 | 2 | GO:0050962 | |
| GeneOntologyBiologicalProcess | response to magnesium ion | 3.83e-04 | 25 | 24 | 2 | GO:0032026 | |
| GeneOntologyBiologicalProcess | regulation of myoblast fusion | 3.83e-04 | 25 | 24 | 2 | GO:1901739 | |
| GeneOntologyBiologicalProcess | regulation of endothelial cell chemotaxis | 4.15e-04 | 26 | 24 | 2 | GO:2001026 | |
| GeneOntologyBiologicalProcess | positive regulation of syncytium formation by plasma membrane fusion | 4.47e-04 | 27 | 24 | 2 | GO:0060143 | |
| GeneOntologyBiologicalProcess | behavioral response to pain | 6.30e-04 | 32 | 24 | 2 | GO:0048266 | |
| GeneOntologyBiologicalProcess | regulation of transmembrane receptor protein serine/threonine kinase signaling pathway | 6.41e-04 | 347 | 24 | 4 | GO:0090092 | |
| GeneOntologyBiologicalProcess | positive regulation of cellular response to transforming growth factor beta stimulus | 7.54e-04 | 35 | 24 | 2 | GO:1903846 | |
| GeneOntologyBiologicalProcess | positive regulation of transforming growth factor beta receptor signaling pathway | 7.54e-04 | 35 | 24 | 2 | GO:0030511 | |
| GeneOntologyBiologicalProcess | endothelial cell chemotaxis | 7.54e-04 | 35 | 24 | 2 | GO:0035767 | |
| GeneOntologyBiologicalProcess | regulation of syncytium formation by plasma membrane fusion | 7.98e-04 | 36 | 24 | 2 | GO:0060142 | |
| GeneOntologyBiologicalProcess | tube development | 8.18e-04 | 1402 | 24 | 7 | GO:0035295 | |
| GeneOntologyBiologicalProcess | negative regulation of cell adhesion | 8.57e-04 | 375 | 24 | 4 | GO:0007162 | |
| GeneOntologyBiologicalProcess | negative regulation of angiogenesis | 1.07e-03 | 175 | 24 | 3 | GO:0016525 | |
| GeneOntologyBiologicalProcess | negative regulation of blood vessel morphogenesis | 1.12e-03 | 178 | 24 | 3 | GO:2000181 | |
| GeneOntologyBiologicalProcess | negative regulation of cell-matrix adhesion | 1.14e-03 | 43 | 24 | 2 | GO:0001953 | |
| GeneOntologyBiologicalProcess | anatomical structure formation involved in morphogenesis | 1.14e-03 | 1483 | 24 | 7 | GO:0048646 | |
| GeneOntologyBiologicalProcess | negative regulation of vasculature development | 1.16e-03 | 180 | 24 | 3 | GO:1901343 | |
| GeneOntologyBiologicalProcess | angiogenesis | 1.16e-03 | 708 | 24 | 5 | GO:0001525 | |
| GeneOntologyBiologicalProcess | regulation of cellular response to growth factor stimulus | 1.21e-03 | 412 | 24 | 4 | GO:0090287 | |
| GeneOntologyBiologicalProcess | regulation of angiogenesis | 1.30e-03 | 420 | 24 | 4 | GO:0045765 | |
| GeneOntologyBiologicalProcess | apoptotic cell clearance | 1.42e-03 | 48 | 24 | 2 | GO:0043277 | |
| GeneOntologyBiologicalProcess | regulation of vasculature development | 1.42e-03 | 430 | 24 | 4 | GO:1901342 | |
| GeneOntologyBiologicalProcess | response to pain | 1.60e-03 | 51 | 24 | 2 | GO:0048265 | |
| GeneOntologyBiologicalProcess | negative chemotaxis | 1.60e-03 | 51 | 24 | 2 | GO:0050919 | |
| GeneOntologyBiologicalProcess | transforming growth factor beta receptor superfamily signaling pathway | 1.61e-03 | 445 | 24 | 4 | GO:0141091 | |
| GeneOntologyBiologicalProcess | semaphorin-plexin signaling pathway | 1.66e-03 | 52 | 24 | 2 | GO:0071526 | |
| GeneOntologyBiologicalProcess | regulation of endothelial cell proliferation | 1.75e-03 | 208 | 24 | 3 | GO:0001936 | |
| GeneOntologyBiologicalProcess | negative regulation of chemotaxis | 1.79e-03 | 54 | 24 | 2 | GO:0050922 | |
| GeneOntologyBiologicalProcess | blood vessel endothelial cell proliferation involved in sprouting angiogenesis | 1.86e-03 | 55 | 24 | 2 | GO:0002043 | |
| GeneOntologyBiologicalProcess | response to BMP | 1.92e-03 | 215 | 24 | 3 | GO:0071772 | |
| GeneOntologyBiologicalProcess | cellular response to BMP stimulus | 1.92e-03 | 215 | 24 | 3 | GO:0071773 | |
| GeneOntologyBiologicalProcess | positive regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction | 1.97e-03 | 217 | 24 | 3 | GO:0051897 | |
| GeneOntologyBiologicalProcess | detection of visible light | 1.99e-03 | 57 | 24 | 2 | GO:0009584 | |
| GeneOntologyBiologicalProcess | myoblast fusion | 2.06e-03 | 58 | 24 | 2 | GO:0007520 | |
| GeneOntologyBiologicalProcess | regulation of chondrocyte differentiation | 2.13e-03 | 59 | 24 | 2 | GO:0032330 | |
| GeneOntologyBiologicalProcess | cell surface receptor protein serine/threonine kinase signaling pathway | 2.16e-03 | 482 | 24 | 4 | GO:0007178 | |
| GeneOntologyBiologicalProcess | blood vessel morphogenesis | 2.19e-03 | 817 | 24 | 5 | GO:0048514 | |
| GeneOntologyBiologicalProcess | negative regulation of developmental process | 2.26e-03 | 1220 | 24 | 6 | GO:0051093 | |
| GeneOntologyBiologicalProcess | visual perception | 2.33e-03 | 230 | 24 | 3 | GO:0007601 | |
| GeneOntologyBiologicalProcess | neural crest cell migration | 2.35e-03 | 62 | 24 | 2 | GO:0001755 | |
| GeneOntologyBiologicalProcess | sensory perception of light stimulus | 2.42e-03 | 233 | 24 | 3 | GO:0050953 | |
| GeneOntologyBiologicalProcess | cellular response to tumor necrosis factor | 2.42e-03 | 233 | 24 | 3 | GO:0071356 | |
| GeneOntologyBiologicalProcess | positive regulation of extrinsic apoptotic signaling pathway | 2.43e-03 | 63 | 24 | 2 | GO:2001238 | |
| GeneOntologyBiologicalProcess | endothelial cell proliferation | 2.48e-03 | 235 | 24 | 3 | GO:0001935 | |
| GeneOntologyBiologicalProcess | mesenchymal cell migration | 2.50e-03 | 64 | 24 | 2 | GO:0090497 | |
| GeneOntologyBiologicalProcess | cellular response to growth factor stimulus | 2.60e-03 | 850 | 24 | 5 | GO:0071363 | |
| GeneOntologyBiologicalProcess | cartilage development | 2.72e-03 | 243 | 24 | 3 | GO:0051216 | |
| GeneOntologyBiologicalProcess | chemotaxis | 2.78e-03 | 517 | 24 | 4 | GO:0006935 | |
| GeneOntologyBiologicalProcess | taxis | 2.82e-03 | 519 | 24 | 4 | GO:0042330 | |
| GeneOntologyBiologicalProcess | response to mechanical stimulus | 2.85e-03 | 247 | 24 | 3 | GO:0009612 | |
| GeneOntologyBiologicalProcess | phagocytosis, engulfment | 2.90e-03 | 69 | 24 | 2 | GO:0006911 | |
| GeneOntologyBiologicalProcess | response to growth factor | 3.06e-03 | 883 | 24 | 5 | GO:0070848 | |
| GeneOntologyBiologicalProcess | regulation of cell-substrate adhesion | 3.08e-03 | 254 | 24 | 3 | GO:0010810 | |
| GeneOntologyBiologicalProcess | response to tumor necrosis factor | 3.22e-03 | 258 | 24 | 3 | GO:0034612 | |
| GeneOntologyBiologicalProcess | negative regulation of cell-substrate adhesion | 3.33e-03 | 74 | 24 | 2 | GO:0010812 | |
| GeneOntologyBiologicalProcess | regulation of endothelial cell apoptotic process | 3.33e-03 | 74 | 24 | 2 | GO:2000351 | |
| GeneOntologyBiologicalProcess | bone development | 3.44e-03 | 264 | 24 | 3 | GO:0060348 | |
| GeneOntologyBiologicalProcess | detection of light stimulus | 3.60e-03 | 77 | 24 | 2 | GO:0009583 | |
| GeneOntologyBiologicalProcess | regulation of endothelial cell migration | 3.63e-03 | 269 | 24 | 3 | GO:0010594 | |
| GeneOntologyBiologicalProcess | plasma membrane invagination | 3.69e-03 | 78 | 24 | 2 | GO:0099024 | |
| GeneOntologyBiologicalProcess | regulation of cell adhesion | 3.78e-03 | 927 | 24 | 5 | GO:0030155 | |
| GeneOntologyBiologicalProcess | endochondral bone morphogenesis | 3.79e-03 | 79 | 24 | 2 | GO:0060350 | |
| GeneOntologyBiologicalProcess | endothelial cell apoptotic process | 3.79e-03 | 79 | 24 | 2 | GO:0072577 | |
| GeneOntologyBiologicalProcess | blood vessel development | 3.81e-03 | 929 | 24 | 5 | GO:0001568 | |
| GeneOntologyBiologicalProcess | axonogenesis | 3.85e-03 | 566 | 24 | 4 | GO:0007409 | |
| GeneOntologyBiologicalProcess | cell junction assembly | 3.93e-03 | 569 | 24 | 4 | GO:0034329 | |
| GeneOntologyBiologicalProcess | regulation of cartilage development | 3.97e-03 | 81 | 24 | 2 | GO:0061035 | |
| GeneOntologyBiologicalProcess | ameboidal-type cell migration | 4.13e-03 | 577 | 24 | 4 | GO:0001667 | |
| GeneOntologyCellularComponent | extracellular matrix | 6.08e-07 | 656 | 25 | 8 | GO:0031012 | |
| GeneOntologyCellularComponent | external encapsulating structure | 6.22e-07 | 658 | 25 | 8 | GO:0030312 | |
| GeneOntologyCellularComponent | collagen-containing extracellular matrix | 2.09e-06 | 530 | 25 | 7 | GO:0062023 | |
| GeneOntologyCellularComponent | basement membrane | 4.06e-04 | 122 | 25 | 3 | GO:0005604 | |
| GeneOntologyCellularComponent | cell-substrate junction | 1.77e-03 | 443 | 25 | 4 | GO:0030055 | |
| Domain | TSP_1 | ADGRB2 ADAMTS12 SEMA5A THBS1 C7 HMCN1 SEMA5B SSPOP ADAMTSL4 UNC5B ADGRB1 | 6.17e-22 | 63 | 24 | 11 | PF00090 |
| Domain | TSP1 | ADGRB2 ADAMTS12 SEMA5A THBS1 C7 HMCN1 SEMA5B SSPOP ADAMTSL4 UNC5B ADGRB1 | 8.96e-22 | 65 | 24 | 11 | SM00209 |
| Domain | TSP1_rpt | ADGRB2 ADAMTS12 SEMA5A THBS1 C7 HMCN1 SEMA5B SSPOP ADAMTSL4 UNC5B ADGRB1 | 8.96e-22 | 65 | 24 | 11 | IPR000884 |
| Domain | TSP1 | ADGRB2 ADAMTS12 SEMA5A THBS1 C7 HMCN1 SEMA5B SSPOP ADAMTSL4 UNC5B ADGRB1 | 8.96e-22 | 65 | 24 | 11 | PS50092 |
| Domain | EGF_3 | 4.14e-07 | 235 | 24 | 6 | PS50026 | |
| Domain | EGF_1 | 6.69e-07 | 255 | 24 | 6 | PS00022 | |
| Domain | EGF_2 | 8.37e-07 | 265 | 24 | 6 | PS01186 | |
| Domain | GPCR_2_brain_angio_inhib | 4.74e-06 | 3 | 24 | 2 | IPR008077 | |
| Domain | EGF-like_dom | 1.40e-05 | 249 | 24 | 5 | IPR000742 | |
| Domain | EGF-like_CS | 1.75e-05 | 261 | 24 | 5 | IPR013032 | |
| Domain | GAIN_dom_N | 8.64e-05 | 11 | 24 | 2 | IPR032471 | |
| Domain | GAIN | 8.64e-05 | 11 | 24 | 2 | PF16489 | |
| Domain | EGF_CA | 1.78e-04 | 86 | 24 | 3 | PF07645 | |
| Domain | VWFD | 1.88e-04 | 16 | 24 | 2 | PS51233 | |
| Domain | VWD | 1.88e-04 | 16 | 24 | 2 | SM00216 | |
| Domain | VWF_type-D | 1.88e-04 | 16 | 24 | 2 | IPR001846 | |
| Domain | VWD | 1.88e-04 | 16 | 24 | 2 | PF00094 | |
| Domain | EGF | 2.13e-04 | 235 | 24 | 4 | SM00181 | |
| Domain | PLAC | 2.67e-04 | 19 | 24 | 2 | IPR010909 | |
| Domain | PLAC | 2.67e-04 | 19 | 24 | 2 | PS50900 | |
| Domain | Semaphorin | 2.96e-04 | 20 | 24 | 2 | IPR027231 | |
| Domain | ADAM_spacer1 | 3.94e-04 | 23 | 24 | 2 | IPR010294 | |
| Domain | ADAM_spacer1 | 3.94e-04 | 23 | 24 | 2 | PF05986 | |
| Domain | HormR | 4.66e-04 | 25 | 24 | 2 | SM00008 | |
| Domain | EGF_CA | 4.98e-04 | 122 | 24 | 3 | SM00179 | |
| Domain | EGF-like_Ca-bd_dom | 5.22e-04 | 124 | 24 | 3 | IPR001881 | |
| Domain | HRM | 5.86e-04 | 28 | 24 | 2 | PF02793 | |
| Domain | SEMA | 7.19e-04 | 31 | 24 | 2 | PS51004 | |
| Domain | Sema | 7.19e-04 | 31 | 24 | 2 | SM00630 | |
| Domain | Semap_dom | 7.19e-04 | 31 | 24 | 2 | IPR001627 | |
| Domain | Sema | 7.19e-04 | 31 | 24 | 2 | PF01403 | |
| Domain | Plexin_repeat | 7.67e-04 | 32 | 24 | 2 | IPR002165 | |
| Domain | PSI | 7.67e-04 | 32 | 24 | 2 | PF01437 | |
| Domain | GPS | 8.66e-04 | 34 | 24 | 2 | SM00303 | |
| Domain | GPS | 9.18e-04 | 35 | 24 | 2 | PF01825 | |
| Domain | VWFC_1 | 9.71e-04 | 36 | 24 | 2 | PS01208 | |
| Domain | GPS | 9.71e-04 | 36 | 24 | 2 | PS50221 | |
| Domain | Growth_fac_rcpt_ | 1.02e-03 | 156 | 24 | 3 | IPR009030 | |
| Domain | GPS | 1.03e-03 | 37 | 24 | 2 | IPR000203 | |
| Domain | VWC | 1.08e-03 | 38 | 24 | 2 | SM00214 | |
| Domain | VWFC_2 | 1.08e-03 | 38 | 24 | 2 | PS50184 | |
| Domain | G_PROTEIN_RECEP_F2_1 | 1.20e-03 | 40 | 24 | 2 | PS00649 | |
| Domain | G_PROTEIN_RECEP_F2_3 | 1.20e-03 | 40 | 24 | 2 | PS50227 | |
| Domain | GPCR_2_extracellular_dom | 1.20e-03 | 40 | 24 | 2 | IPR001879 | |
| Domain | LDLR_class-A_CS | 1.20e-03 | 40 | 24 | 2 | IPR023415 | |
| Domain | VWF_dom | 1.32e-03 | 42 | 24 | 2 | IPR001007 | |
| Domain | PSI | 1.45e-03 | 44 | 24 | 2 | IPR016201 | |
| Domain | Ldl_recept_a | 1.51e-03 | 45 | 24 | 2 | PF00057 | |
| Domain | PSI | 1.58e-03 | 46 | 24 | 2 | SM00423 | |
| Domain | - | 1.58e-03 | 46 | 24 | 2 | 4.10.400.10 | |
| Domain | LDLRA_1 | 1.72e-03 | 48 | 24 | 2 | PS01209 | |
| Domain | LDrepeatLR_classA_rpt | 1.79e-03 | 49 | 24 | 2 | IPR002172 | |
| Domain | LDLa | 1.79e-03 | 49 | 24 | 2 | SM00192 | |
| Domain | LDLRA_2 | 1.79e-03 | 49 | 24 | 2 | PS50068 | |
| Domain | G_PROTEIN_RECEP_F2_2 | 1.87e-03 | 50 | 24 | 2 | PS00650 | |
| Domain | 7tm_2 | 1.87e-03 | 50 | 24 | 2 | PF00002 | |
| Domain | GPCR_2-like | 2.68e-03 | 60 | 24 | 2 | IPR017981 | |
| Domain | GPCR_2_secretin-like | 2.68e-03 | 60 | 24 | 2 | IPR000832 | |
| Domain | G_PROTEIN_RECEP_F2_4 | 2.77e-03 | 61 | 24 | 2 | PS50261 | |
| Pathway | REACTOME_DISEASES_ASSOCIATED_WITH_O_GLYCOSYLATION_OF_PROTEINS | 1.35e-12 | 68 | 18 | 7 | M27303 | |
| Pathway | REACTOME_O_GLYCOSYLATION_OF_TSR_DOMAIN_CONTAINING_PROTEINS | 5.43e-12 | 39 | 18 | 6 | M27417 | |
| Pathway | REACTOME_O_GLYCOSYLATION_OF_TSR_DOMAIN_CONTAINING_PROTEINS | 5.43e-12 | 39 | 18 | 6 | MM15165 | |
| Pathway | REACTOME_O_LINKED_GLYCOSYLATION | 4.03e-11 | 109 | 18 | 7 | MM15164 | |
| Pathway | REACTOME_O_LINKED_GLYCOSYLATION | 4.59e-11 | 111 | 18 | 7 | M27416 | |
| Pathway | REACTOME_DISEASES_OF_GLYCOSYLATION | 2.76e-10 | 143 | 18 | 7 | M27275 | |
| Pathway | REACTOME_DISEASES_OF_METABOLISM | 1.37e-08 | 250 | 18 | 7 | M27554 | |
| Pathway | KEGG_AXON_GUIDANCE | 5.52e-04 | 129 | 18 | 3 | M5539 | |
| Pathway | REACTOME_POST_TRANSLATIONAL_PROTEIN_MODIFICATION | 1.06e-03 | 1389 | 18 | 7 | MM15307 | |
| Pathway | REACTOME_POST_TRANSLATIONAL_PROTEIN_MODIFICATION | 1.52e-03 | 1475 | 18 | 7 | M19806 | |
| Pubmed | ADGRB2 ADAMTS12 SEMA5A THBS1 HMCN1 SEMA5B SSPOP ADAMTSL4 ADGRB1 | 1.22e-18 | 75 | 25 | 9 | 20637190 | |
| Pubmed | 3.68e-07 | 210 | 25 | 5 | 16537572 | ||
| Pubmed | Novel ADAMTSL4 gene mutations in Chinese patients with isolated ectopia lentis. | 4.96e-07 | 2 | 25 | 2 | 35042684 | |
| Pubmed | 1.49e-06 | 3 | 25 | 2 | 9533023 | ||
| Pubmed | 1.49e-06 | 3 | 25 | 2 | 15225653 | ||
| Pubmed | 4.95e-06 | 5 | 25 | 2 | 8817451 | ||
| Pubmed | 4.95e-06 | 5 | 25 | 2 | 25313870 | ||
| Pubmed | 7.08e-06 | 52 | 25 | 3 | 26633812 | ||
| Pubmed | 7.21e-06 | 175 | 25 | 4 | 28071719 | ||
| Pubmed | 7.43e-06 | 6 | 25 | 2 | 15281082 | ||
| Pubmed | Proteomic characterization of human multiple myeloma bone marrow extracellular matrix. | 1.21e-05 | 62 | 25 | 3 | 28344315 | |
| Pubmed | 1.33e-05 | 64 | 25 | 3 | 22261194 | ||
| Pubmed | Invariant Sema5A inhibition serves an ensheathing function during optic nerve development. | 1.39e-05 | 8 | 25 | 2 | 12506007 | |
| Pubmed | 1.78e-05 | 9 | 25 | 2 | 8812066 | ||
| Pubmed | 1.78e-05 | 9 | 25 | 2 | 15743826 | ||
| Pubmed | Transcriptome-based systematic identification of extracellular matrix proteins. | 2.50e-05 | 79 | 25 | 3 | 18757743 | |
| Pubmed | Extracellular matrix secretion by cardiac fibroblasts: role of microRNA-29b and microRNA-30c. | 2.84e-05 | 248 | 25 | 4 | 24006456 | |
| Pubmed | 5.67e-05 | 985 | 25 | 6 | 12975309 | ||
| Pubmed | 8.42e-05 | 19 | 25 | 2 | 12543931 | ||
| Pubmed | 8.42e-05 | 19 | 25 | 2 | 15051154 | ||
| Pubmed | 1.01e-04 | 126 | 25 | 3 | 16284245 | ||
| Pubmed | Class 5 transmembrane semaphorins control selective Mammalian retinal lamination and function. | 1.03e-04 | 21 | 25 | 2 | 21835343 | |
| Pubmed | 1.79e-04 | 153 | 25 | 3 | 25037231 | ||
| Pubmed | 1.85e-04 | 28 | 25 | 2 | 18617019 | ||
| Pubmed | The human and mouse repertoire of the adhesion family of G-protein-coupled receptors. | 1.99e-04 | 29 | 25 | 2 | 15203201 | |
| Pubmed | Noggin is required for correct guidance of dorsal root ganglion axons. | 1.99e-04 | 29 | 25 | 2 | 12435358 | |
| Pubmed | 2.11e-04 | 417 | 25 | 4 | 19199708 | ||
| Pubmed | 2.28e-04 | 31 | 25 | 2 | 24014668 | ||
| Pubmed | 2.31e-04 | 167 | 25 | 3 | 22159717 | ||
| Pubmed | International Union of Basic and Clinical Pharmacology. XCIV. Adhesion G protein-coupled receptors. | 2.58e-04 | 33 | 25 | 2 | 25713288 | |
| Pubmed | 3.25e-04 | 37 | 25 | 2 | 20236931 | ||
| Pubmed | 3.25e-04 | 37 | 25 | 2 | 38011284 | ||
| Pubmed | Dynamic spatiotemporal gene expression in embryonic mouse thalamus. | 4.00e-04 | 41 | 25 | 2 | 21192082 | |
| Pubmed | 5.26e-04 | 47 | 25 | 2 | 35462405 | ||
| Pubmed | Calsyntenins function as synaptogenic adhesion molecules in concert with neurexins. | 6.43e-04 | 52 | 25 | 2 | 24613359 | |
| Interaction | PLSCR1 interactions | 4.00e-05 | 172 | 23 | 4 | int:PLSCR1 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr5p13 | 2.61e-03 | 139 | 25 | 2 | chr5p13 | |
| GeneFamily | Adhesion G protein-coupled receptors, subfamily B | 2.50e-06 | 3 | 17 | 2 | 912 | |
| GeneFamily | Immunoglobulin like domain containing|Semaphorins | 1.57e-04 | 20 | 17 | 2 | 736 | |
| GeneFamily | Blood group antigens|CD molecules|I-set domain containing|Immunoglobulin like domain containing | 9.82e-03 | 161 | 17 | 2 | 593 | |
| Coexpression | NABA_MATRISOME | ADAMTS12 SEMA5A BMP6 THBS1 COL17A1 HMCN1 SEMA5B SSPOP MUC4 ADAMTSL4 NPNT | 2.28e-10 | 1008 | 23 | 11 | MM17056 |
| Coexpression | NABA_MATRISOME | ADAMTS12 SEMA5A BMP6 THBS1 COL17A1 HMCN1 SEMA5B SSPOP MUC4 ADAMTSL4 NPNT | 2.75e-10 | 1026 | 23 | 11 | M5889 |
| Coexpression | NABA_CORE_MATRISOME | 3.23e-06 | 270 | 23 | 5 | MM17057 | |
| Coexpression | NABA_CORE_MATRISOME | 3.53e-06 | 275 | 23 | 5 | M5884 | |
| Coexpression | BERTUCCI_MEDULLARY_VS_DUCTAL_BREAST_CANCER_DN | 1.72e-05 | 180 | 23 | 4 | M10605 | |
| Coexpression | NABA_ECM_GLYCOPROTEINS | 2.17e-05 | 191 | 23 | 4 | MM17059 | |
| Coexpression | NABA_ECM_GLYCOPROTEINS | 2.40e-05 | 196 | 23 | 4 | M3008 | |
| Coexpression | NABA_MATRISOME_ASSOCIATED | 3.27e-05 | 738 | 23 | 6 | MM17058 | |
| Coexpression | NABA_MATRISOME_ASSOCIATED | 3.61e-05 | 751 | 23 | 6 | M5885 | |
| Coexpression | HE_LIM_SUN_FETAL_LUNG_C3_VENOUS_ENDOTHELIAL_CELL | 5.56e-05 | 85 | 23 | 3 | M45761 | |
| Coexpression | CLASPER_LYMPHATIC_VESSELS_DURING_METASTASIS_UP | 1.39e-04 | 20 | 23 | 2 | MM706 | |
| Coexpression | CLASPER_LYMPHATIC_VESSELS_DURING_METASTASIS_UP | 1.39e-04 | 20 | 23 | 2 | M11701 | |
| Coexpression | GUENTHER_GROWTH_SPHERICAL_VS_ADHERENT_UP | 1.68e-04 | 22 | 23 | 2 | M7184 | |
| Coexpression | NABA_MATRISOME_POORLY_METASTATIC_BREAST_CANCER | 2.18e-04 | 25 | 23 | 2 | M47986 | |
| Coexpression | MEISSNER_BRAIN_HCP_WITH_H3K4ME3_AND_H3K27ME3 | 2.59e-04 | 1074 | 23 | 6 | M1941 | |
| Coexpression | JAK2_DN.V1_DN | 2.82e-04 | 147 | 23 | 3 | M2872 | |
| Coexpression | NABA_ECM_AFFILIATED | 3.48e-04 | 158 | 23 | 3 | MM17063 | |
| Coexpression | ZHAN_LATE_DIFFERENTIATION_GENES_UP | 3.83e-04 | 33 | 23 | 2 | M10280 | |
| Coexpression | SCHAEFFER_PROSTATE_DEVELOPMENT_48HR_DN | 4.17e-04 | 411 | 23 | 4 | M1351 | |
| Coexpression | NABA_ECM_AFFILIATED | 4.31e-04 | 170 | 23 | 3 | M5880 | |
| Coexpression | SCHAEFFER_PROSTATE_DEVELOPMENT_48HR_DN | 4.36e-04 | 416 | 23 | 4 | MM1002 | |
| Coexpression | NABA_BASEMENT_MEMBRANES | 5.63e-04 | 40 | 23 | 2 | M5887 | |
| Coexpression | AKT_UP.V1_DN | 5.70e-04 | 187 | 23 | 3 | M2666 | |
| Coexpression | GSE5542_UNTREATED_VS_IFNG_TREATED_EPITHELIAL_CELLS_24H_UP | 6.73e-04 | 198 | 23 | 3 | M6522 | |
| Coexpression | GSE22935_UNSTIM_VS_24H_MBOVIS_BCG_STIM_MYD88_KO_MACROPHAGE_DN | 6.93e-04 | 200 | 23 | 3 | M7771 | |
| Coexpression | GSE40666_UNTREATED_VS_IFNA_STIM_EFFECTOR_CD8_TCELL_90MIN_UP | 6.93e-04 | 200 | 23 | 3 | M9235 | |
| Coexpression | GSE36392_EOSINOPHIL_VS_MAC_IL25_TREATED_LUNG_UP | 6.93e-04 | 200 | 23 | 3 | M5280 | |
| Coexpression | GSE17721_PAM3CSK4_VS_CPG_12H_BMDC_DN | 6.93e-04 | 200 | 23 | 3 | M3868 | |
| Coexpression | GSE20715_0H_VS_24H_OZONE_TLR4_KO_LUNG_DN | 6.93e-04 | 200 | 23 | 3 | M4375 | |
| Coexpression | ZENG_GU_ICB_CONTROL_METAGENE_31_PRECICTIVE_ICB_RESISTANCE | 7.03e-04 | 201 | 23 | 3 | MM17086 | |
| CoexpressionAtlas | FacebaseRNAseq_ratio_e9.5_MandibularArch_vs_MaxillaryArch_top-relative-expression-ranked_1000 | 6.96e-05 | 967 | 24 | 7 | Facebase_RNAseq_ratio_e9.5_MandibularArch_vs_MaxillaryArch_1000 | |
| CoexpressionAtlas | BM Top 100 - lung | 7.19e-05 | 72 | 24 | 3 | BM Top 100 - lung | |
| CoexpressionAtlas | Progenitor-Cell-Biology-Consortium_reference_CardiacMyocyte_top-relative-expression-ranked_1000 | 7.33e-05 | 975 | 24 | 7 | PCBC_ctl_CardiacMyocyte_1000 | |
| CoexpressionAtlas | EB amniotic fluid MSC_vs_EB blastocyst-Confounder_removed-fold2.0_adjp0.05 | 1.25e-04 | 727 | 24 | 6 | PCBC_ratio_EB amniotic fluid MSC_vs_EB blastocyst_cfr-2X-p05 | |
| CoexpressionAtlas | Stromal Cells, FRC.MLN, gp38+ CD31- CD140a+, Lymph Node, avg-5 | 1.50e-04 | 466 | 24 | 5 | GSM777050_500 | |
| CoexpressionAtlas | DevelopingKidney_e15.5_Pelvic Mesenchyme_emap-8241_k-means-cluster#2_top-relative-expression-ranked_100 | 1.65e-04 | 17 | 24 | 2 | gudmap_developingKidney_e15.5_Pelvic Mesenchyme_100_k2 | |
| CoexpressionAtlas | facebase_RNAseq_e14.5_palate_poster_distal_ERK2_WT_2500_K1 | 2.24e-04 | 1166 | 24 | 7 | facebase_RNAseq_e14.5_palate_poster_distal_ERK2_WT_2500_K1 | |
| CoexpressionAtlas | facebase_RNAseq_e14.5_palate_poster_proximal_ERK2_WT_2500_K2 | 2.79e-04 | 1208 | 24 | 7 | facebase_RNAseq_e14.5_palate_poster_proximal_ERK2_WT_2500_K2 | |
| CoexpressionAtlas | kidney_P0_CapMes_Crym_k-means-cluster#4_top-relative-expression-ranked_200 | 2.79e-04 | 22 | 24 | 2 | gudmap_kidney_P0_CapMes_Crym_k4_200 | |
| CoexpressionAtlas | FacebaseRNAseq_e8.5_Non-Floor Plate Neural Epithelium_top-relative-expression-ranked_2500_k-means-cluster#1 | 3.49e-04 | 878 | 24 | 6 | Facebase_RNAseq_e8.5_Non-Floor Plate Neural Epithelium_2500_K1 | |
| CoexpressionAtlas | FacebaseRNAseq_ratio_e10.5_MandibularArch_vs_MaxillaryArch_top-relative-expression-ranked_2500_k-means-cluster#4 | 4.50e-04 | 591 | 24 | 5 | Facebase_RNAseq_ratio_e10.5_MandibularArch_vs_MaxillaryArch_2500_K4 | |
| ToppCell | facs-Skin-Anagen-3m-Epithelial-bulge_keratinocyte|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.49e-08 | 193 | 24 | 5 | eba3c70701b051bc1ed1f4db9270cb27a77ffc3e | |
| ToppCell | facs-Skin-Anagen-3m-Epithelial-outer_bulge|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.63e-08 | 194 | 24 | 5 | 5d30d3d41d5f19cdf3077cc609aa2738762cb8c5 | |
| ToppCell | 3'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_2-Alveolar_fibroblasts-Alveolar_fibroblasts_L.2.1.1.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 6.08e-08 | 197 | 24 | 5 | 94a9603cbd3516fbcce871909693b88f20d41713 | |
| ToppCell | Bronchial_Biopsy-Endothelial-Lymphatic|Endothelial / Tissue, Lineage and Cell class of Lung Cells from 10X | 1.67e-06 | 163 | 24 | 4 | 961c3a1303108afd680365466045f3460a30a7b0 | |
| ToppCell | 5'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_2-Alveolar_fibroblasts-Alveolar_fibroblasts_L.2.1.1.1|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.82e-06 | 186 | 24 | 4 | 5473283fb95cee556b1f6934cf72169b676b5bcc | |
| ToppCell | 11.5-Airway-Mesenchymal-Pericyte|Airway / Age, Tissue, Lineage and Cell class | 2.94e-06 | 188 | 24 | 4 | 916971d8660fd20f616346953874e89d2cd13e88 | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-matrix_fibroblast_1_cell-D150|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 3.00e-06 | 189 | 24 | 4 | 203c80030df08ae112f9ae4043709f455d87ce89 | |
| ToppCell | (5)_Fibroblasts-(5)_Fibroblast-C_(Myofibroblast)|(5)_Fibroblasts / Lung cell shreds - cell class (v4) and cell subclass (v4) | 3.06e-06 | 190 | 24 | 4 | 71e112dfb8c3190fe0286b45a046ea789eb6a8db | |
| ToppCell | Control-Fibroblasts|Control / group, cell type (main and fine annotations) | 3.06e-06 | 190 | 24 | 4 | 3a42a9b98d954685d38a741f44545898d0e3e9ce | |
| ToppCell | LPS_only-Stromal_mesenchymal-Matrix_Fibroblast-Diff_MatrixFB|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.06e-06 | 190 | 24 | 4 | d60395739458d7f47a3350ade751fe3819500320 | |
| ToppCell | LPS-IL1RA+antiTNF-Stromal_mesenchymal-Matrix_Fibroblast-Activated_MatrixFB|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.13e-06 | 191 | 24 | 4 | b13229bb7f3713a392271aaf5dbae3edd1b9fe5a | |
| ToppCell | nucseq-Mesenchymal-Fibroblastic-Fibroblastic_2-AF1|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 3.13e-06 | 191 | 24 | 4 | 6688cee34beee4f151ac17fccbc9c26a9aad72e1 | |
| ToppCell | LPS-IL1RA+antiTNF-Stromal_mesenchymal-Matrix_Fibroblast|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.19e-06 | 192 | 24 | 4 | 6f4ef24dab544681304b7f8a9dc073e7edaa4cf5 | |
| ToppCell | LPS-IL1RA+antiTNF-Stromal_mesenchymal|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.19e-06 | 192 | 24 | 4 | 3d0cb19f037f604253d7d728689aeaa94251e92b | |
| ToppCell | PCW_13-14-Mesenchymal-Mesenchymal_fibroblastic-mes_immature_COL13A1^pos_fibro1_(4)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 3.26e-06 | 193 | 24 | 4 | 9f69edc97b868d23998abc98928a2e89a885ef8a | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast-|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 3.26e-06 | 193 | 24 | 4 | 5b602b1702283184bd3943c2a6f2290b7c37e407 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 3.26e-06 | 193 | 24 | 4 | c8c21eee8c6c086dc2faf416669cd4a002870fbe | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-matrix_fibroblast_1_cell-D062|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 3.33e-06 | 194 | 24 | 4 | 35f132cc38ac133be01834ed0946188aa0757eb4 | |
| ToppCell | Control-Stromal-Myofibroblast|World / Disease state, Lineage and Cell class | 3.33e-06 | 194 | 24 | 4 | 3c2266772c5b56e8e02a461e5193e29588028ee9 | |
| ToppCell | LPS-antiTNF-Stromal_mesenchymal|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.33e-06 | 194 | 24 | 4 | 6e13549f697f7478b34fe71f7dd9d63c5d3db22e | |
| ToppCell | Control-Fibroblasts-Intermediate_pathological_FB|Control / group, cell type (main and fine annotations) | 3.33e-06 | 194 | 24 | 4 | 03a269f75a481ea54aea8e6444605db8d6df493d | |
| ToppCell | (5)_Fibroblast-C_(Myofibroblast)|World / Lung cell shreds - cell class (v4) and cell subclass (v4) | 3.33e-06 | 194 | 24 | 4 | 29a72e565c19407bbd198cfbc2a78106fe830d05 | |
| ToppCell | LPS-antiTNF-Stromal_mesenchymal-Matrix_Fibroblast-Activated_MatrixFB|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.33e-06 | 194 | 24 | 4 | 89b706af2b25991fc2707eb24f49ba6ff3ae01f7 | |
| ToppCell | kidney_cells-Renal_AKI_(acute_kidney_injury)-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell-Descending_Thin_Limb_Cell_Type_2|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 3.33e-06 | 194 | 24 | 4 | 8ddcaaf24cee6e30d5be52c0cbf778cfba309c53 | |
| ToppCell | 5'-GW_trimst-2-LymphNode-Mesenchymal-fibroblastic-mLTo|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.33e-06 | 194 | 24 | 4 | c45e9d09b5cd6973de6c3f1713b3bf36fa4bfe57 | |
| ToppCell | PCW_10-12-Mesenchymal-Mesenchymal_fibroblastic-mes_immature_COL13A1^pos_fibro1_(4)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 3.33e-06 | 194 | 24 | 4 | 71d3c7448b1734de54187f902f65649f9283bd4c | |
| ToppCell | Control-Stromal-Myofibroblast|Control / Disease state, Lineage and Cell class | 3.40e-06 | 195 | 24 | 4 | ffcf76cd72e43d8cf1058a49c76e0956065038bc | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Mesenchymal|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 3.40e-06 | 195 | 24 | 4 | d8ebb94f30d4a655d6b29dd6a3076be2403d2356 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 3.40e-06 | 195 | 24 | 4 | 783bfa8110161cbd6def50ce849cae676c39c458 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast-|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 3.40e-06 | 195 | 24 | 4 | cad6563cc51d212554152c727fc2c249c6a07e4d | |
| ToppCell | 5'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_2-Alveolar_fibroblasts-Alveolar_fibroblasts_L.2.1.1.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.40e-06 | 195 | 24 | 4 | df409f94f4e83be89f7a608058ee07ce3ce3a149 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast-|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 3.47e-06 | 196 | 24 | 4 | 3a6c942e2907aa07b5e12dbf9019d18f7bfca507 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 3.47e-06 | 196 | 24 | 4 | bba88e91cd3e3a6f5a9b443e3a4da33c5b455e70 | |
| ToppCell | facs-Skin-Telogen-3m-Epithelial-bulge_keratinocyte|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.47e-06 | 196 | 24 | 4 | 90edf61116ffcb4f8b6be3d0a05732d59b0a87d5 | |
| ToppCell | 3'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_2-Alveolar_fibroblasts|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.47e-06 | 196 | 24 | 4 | cecf82cd5e0a3835d655f5e7478578674a63ce25 | |
| ToppCell | 3'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_2|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.47e-06 | 196 | 24 | 4 | 9737a5f006d37b549f281e1863aca558e1e4dc99 | |
| ToppCell | facs-Skin-Telogen-3m-Epithelial-outer_bulge|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.47e-06 | 196 | 24 | 4 | c936014125b2ed5f796221b74acb77b8f8359875 | |
| ToppCell | LPS_IL1RA_TNF|World / Treatment groups by lineage, cell group, cell type | 3.54e-06 | 197 | 24 | 4 | 0a6550dce156fc81f15b1e7830d331ca50d87d06 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 3.54e-06 | 197 | 24 | 4 | 09946ee8dfb15a2a32da06e5b331f3277ee934f4 | |
| ToppCell | COVID-19-Fibroblasts-Intermediate_pathological_FB|COVID-19 / group, cell type (main and fine annotations) | 3.54e-06 | 197 | 24 | 4 | f1c8936986123a3151140c374fcd62d6705c530b | |
| ToppCell | COPD-Stromal-Myofibroblast|World / Disease state, Lineage and Cell class | 3.54e-06 | 197 | 24 | 4 | d51f484b4e01ac64233950d0b97fa88825ea1dbb | |
| ToppCell | COVID-19-Fibroblasts|COVID-19 / group, cell type (main and fine annotations) | 3.54e-06 | 197 | 24 | 4 | fb847f2277609c31fffcdf49517243ce0684facf | |
| ToppCell | 3'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_2-Alveolar_fibroblasts-Alveolar_fibroblasts_L.2.1.1.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.54e-06 | 197 | 24 | 4 | 13896ec65ccda0b928c91d41112dc01b480036b7 | |
| ToppCell | normal_Lung-Fibroblasts-COL13A1+_matrix_FBs|normal_Lung / Location, Cell class and cell subclass | 3.54e-06 | 197 | 24 | 4 | 6c57ab2efb8363828e24211c4d45e58bb73a9a4d | |
| ToppCell | IPF-Stromal-Myofibroblast|Stromal / Disease state, Lineage and Cell class | 3.54e-06 | 197 | 24 | 4 | f304d42fc4936fe20996e07c8dccc698a6e5e5ef | |
| ToppCell | COVID-19-lung-Fibroblast|lung / Disease (COVID-19 only), tissue and cell type | 3.61e-06 | 198 | 24 | 4 | df3de77216f5c5d6141ec44d01c56b942f611838 | |
| ToppCell | COVID-19-lung-Fibroblast|COVID-19 / Disease (COVID-19 only), tissue and cell type | 3.61e-06 | 198 | 24 | 4 | 3ec01a55ade5e1627258cc3cfebb2c3207a4cb43 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Mesenchymal|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 3.61e-06 | 198 | 24 | 4 | 79576525a10ed3e3a9d1608077cd16ecda23376f | |
| ToppCell | background-Hepatic_Stellate_cells|World / Sample and Cell Type and Tumor Cluster (all cells) | 3.61e-06 | 198 | 24 | 4 | 79f32f965aed6a10c5cb803173e3db7b32e07a91 | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 3.61e-06 | 198 | 24 | 4 | 21cf4d81386761d09d0f6829c01c198e5524176d | |
| ToppCell | cellseq-Mesenchymal-Fibroblastic-Fibroblastic_2-AF1|cellseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 3.61e-06 | 198 | 24 | 4 | f1374f7a50244d59c766ac41f44c08c9117407d2 | |
| ToppCell | proximal-mesenchymal-Alveolar_Fibroblast|proximal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 3.68e-06 | 199 | 24 | 4 | 7f4840ae6a888380feca722543e5e52783f3e35d | |
| ToppCell | proximal-3-mesenchymal-Alveolar_Fibroblast|3 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 3.68e-06 | 199 | 24 | 4 | 301d02bbb37e6f1d24b6e865bc3fe3e91260eb30 | |
| ToppCell | LPS_IL1RA_TNF-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 3.68e-06 | 199 | 24 | 4 | 30d3e8c0681ec11f86dd38c5f48d21187a1b4f90 | |
| ToppCell | cellseq-Mesenchymal-Fibroblastic-Fibroblastic_2|cellseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 3.68e-06 | 199 | 24 | 4 | 66a79732caf2f04c09b4d9832377aa01ca477677 | |
| ToppCell | proximal-mesenchymal-Alveolar_Fibroblast-3|proximal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 3.68e-06 | 199 | 24 | 4 | 9a16e519fb0651a7c4d8e05b931df4fb3b0eb3d1 | |
| ToppCell | LPS_IL1RA-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 3.68e-06 | 199 | 24 | 4 | a7dd94b172c973a131a6792f8ccd9bfe44d984ac | |
| ToppCell | LPS_anti-TNF-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 3.76e-06 | 200 | 24 | 4 | 9b0916d8d07ac2bf1739f7be5296bf77ffee6094 | |
| ToppCell | Parenchymal-NucSeq-Stromal|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 3.76e-06 | 200 | 24 | 4 | cf433f9b43d7db07acaf70e060f8f77c974e72f3 | |
| ToppCell | LPS_IL1RA_TNF-Mesenchymal_fibroblastic-Fibroblasts|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 3.76e-06 | 200 | 24 | 4 | 44a68bacdb3d5bf563bd35952176995850933a81 | |
| ToppCell | Bronchial-NucSeq-Stromal-Fibroblastic|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 3.76e-06 | 200 | 24 | 4 | cae972324d1dfea6efeaf6013f265c7c6bb48db4 | |
| ToppCell | LPS_anti-TNF-Mesenchymal_fibroblastic-Fibroblasts|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 3.76e-06 | 200 | 24 | 4 | b79628fd1386aa9a3b0e9fa81def0bc100c3c073 | |
| ToppCell | Bronchial-10x5prime-Stromal-Fibroblastic-Fibro_alveolar|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 3.76e-06 | 200 | 24 | 4 | cb31cfcfa8e6d6cc610c4c22e97bc009dd8a9e7c | |
| ToppCell | LPS_anti-TNF-Mesenchymal_fibroblastic|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 3.76e-06 | 200 | 24 | 4 | 50ca6550998e461ef26dd670351060bd940765a8 | |
| ToppCell | Bronchial-NucSeq-Stromal-Fibroblastic-Fibro_alveolar|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 3.76e-06 | 200 | 24 | 4 | e8462395fee0a532d1e7ec7f1795f28c42af6541 | |
| ToppCell | Tracheal-10x5prime-Stromal-Fibroblastic-Fibro_immune_recruiting|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 3.76e-06 | 200 | 24 | 4 | f692b602bc989d35c9162e73dda813dbef8d5267 | |
| ToppCell | Parenchymal-10x5prime-Stromal-Fibroblastic-Fibro_alveolar|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 3.76e-06 | 200 | 24 | 4 | 8c62f05c6042f24287a73fbdf80ff4a56f7ff403 | |
| ToppCell | Parenchyma_Control_(B.)-Stromal-TX-Fibroblasts-1|Parenchyma_Control_(B.) / Sample group, Lineage and Cell type | 3.76e-06 | 200 | 24 | 4 | aa1a35dcca3b799241eef4237f6eb94660e019f0 | |
| ToppCell | Parenchymal-NucSeq-Stromal-Fibroblastic|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 3.76e-06 | 200 | 24 | 4 | 311fab076f2ceb258e3970eb21e39344b894042a | |
| ToppCell | LPS_IL1RA_TNF-Mesenchymal_fibroblastic|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 3.76e-06 | 200 | 24 | 4 | dc61016c61729f69649cfb21f6264e685ce83dea | |
| ToppCell | Parenchymal-NucSeq-Stromal-Fibroblastic-Fibro_alveolar|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 3.76e-06 | 200 | 24 | 4 | 34f52003988ce6329d8deeee1ab875fa77e01e9d | |
| ToppCell | (01)_IL1RL1+|World / shred by cell type by condition | 3.76e-06 | 200 | 24 | 4 | 501420901bf3ec1b050e0d14596a9f9f3fdfc928 | |
| ToppCell | LPS_anti-TNF-Mesenchymal_fibroblastic-Fibroblasts-Diff_MatrixFB|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 3.76e-06 | 200 | 24 | 4 | 3bdba9612cd7c612b76aa9abecc4a6529aabfc1c | |
| ToppCell | Lung_Parenchyma-Control-Mesenchymal-Mesenchymal-Fibroblasts-1|Control / Location, Disease Group, Cell group, Cell class (2021.03.09) | 3.76e-06 | 200 | 24 | 4 | a510deaada669e690329183e18df02870bd204b3 | |
| ToppCell | Lung_Parenchyma-Control-Mesenchymal-Mesenchymal-Fibroblasts-1-|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 3.76e-06 | 200 | 24 | 4 | dd4228cbed8a4395166a6332e08d44d88bebe3b9 | |
| ToppCell | Posterior_cortex-Macroglia-POLYDENDROCYTE-P1-P1_1-Trf-Oligodendrocyte.Tfr.Ctps_(Ctps)|Posterior_cortex / BrainAtlas - Mouse McCarroll V32 | 1.52e-05 | 90 | 24 | 3 | 4d75217fd6b376bfda3300962cbe4875b31ffdaf | |
| ToppCell | COVID-19_Mild-Neu_3|World / 5 Neutrophil clusters in COVID-19 patients | 3.78e-05 | 122 | 24 | 3 | 2aa9cfadab70312882ae679e3788fc7ab996c0f3 | |
| ToppCell | primary_visual_cortex-Non-neuronal-oligodendrocyte-Oligo-Oligo_Synpr|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 4.99e-05 | 134 | 24 | 3 | 3dd4b5eddc94c1d49ab23b287ee234db3a55331b | |
| ToppCell | frontal_cortex-Non-neuronal-oligodendrocyte-Oligo-Oligo_Synpr|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 5.33e-05 | 137 | 24 | 3 | b03f19b233c1c809f2cd2b4a7642eeaf254a6289 | |
| ToppCell | URO-Lymphocyte-T_NK-CD8_TCM|URO / Disease, Lineage and Cell Type | 5.81e-05 | 141 | 24 | 3 | 53aef819f505238011f8a3202445f31055791d05 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-Collagen-high_Fibroblast-|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 6.98e-05 | 150 | 24 | 3 | 1270f33f9d7e46e55adf1a96e8beee858b95589d | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-Collagen-high_Fibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 6.98e-05 | 150 | 24 | 3 | 156118ce1d69522624196410cba18b8354cd0bb4 | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Glial-Neuronal-OPC-OPC-E|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 7.70e-05 | 155 | 24 | 3 | 77fdae85d36efb776db977eb424b32487ef222e4 | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Epithelial-Renal_corpuscle_epithelial_cell-glomerular_visceral_epithelial_cell-Podocyte|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 8.30e-05 | 159 | 24 | 3 | fd7db2f7328cfefdc3ada2af91006d5a91d137e1 | |
| ToppCell | Bronchial-10x5prime-Stromal-Myofibroblastic-Muscle_smooth_airway_ASM|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 8.30e-05 | 159 | 24 | 3 | 7cda111bb98f1241989e49d490bdf51a712ea589 | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Epithelial-Renal_corpuscle_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 8.30e-05 | 159 | 24 | 3 | aaf449c768d6fbb0a1bb47746ff3bdb7f9eb8914 | |
| ToppCell | Adult-Mesenchymal-chondrocyte|Adult / Lineage, Cell type, age group and donor | 8.30e-05 | 159 | 24 | 3 | 3f7305ee76447064b5c846c4f576360a2f7e0b7c | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Epithelial-Renal_corpuscle_epithelial_cell-glomerular_visceral_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 8.30e-05 | 159 | 24 | 3 | 8bbdef1e927f3130b578d7d7c5ff38bbe06fab63 | |
| ToppCell | Adult-Mesenchymal-vascular_smooth_muscle_cell-D122|Adult / Lineage, Cell type, age group and donor | 8.46e-05 | 160 | 24 | 3 | fd14dfeb7021a4b7299371854dc8fc1fd66c8dae | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-Collagen-high_Fibroblast-|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 8.77e-05 | 162 | 24 | 3 | 5f009b231f21861afee9cc0c569082e1135f929c | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-Collagen-high_Fibroblast|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 8.77e-05 | 162 | 24 | 3 | b936f8040dcd4db621ccded19237af8df7d0ed6e | |
| ToppCell | Transplant_Alveoli_and_parenchyma-Epithelial-Basal_2|Epithelial / Tissue, Lineage and Cell class of Lung Cells from 10X | 8.93e-05 | 163 | 24 | 3 | f21951e63188eb0c04675a8f81a0da495c26c007 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_1-Inh_L1-6_VIP_PENK|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 9.94e-05 | 169 | 24 | 3 | eb3b8e473192c4b8688f2f8da400116dd6fe193d | |
| ToppCell | droplet-Kidney-nan-18m-Epithelial-Pecam____kidney_capillary_endothelial_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.94e-05 | 169 | 24 | 3 | 87116c33c5ca8cb1862e103e5607b1df4d264569 | |
| ToppCell | droplet-Liver-LIVER_HEPATOCYTES-30m-Endothelial-endothelial_cell_of_hepatic_sinusoid|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.01e-04 | 170 | 24 | 3 | 50c6c571591aa4b218caefe5778c570c809f567e | |
| ToppCell | Smart-seq2-tissue-resident_(Smart-seq2)-myeloid-myeloid_dendritic-CD1c-positive_myeloid_dendritic_cell|tissue-resident_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 1.01e-04 | 170 | 24 | 3 | cc66ac6846c58be9493eb270644ee3ce0f86cfea | |
| ToppCell | droplet-Liver-LIVER_HEPATOCYTES-30m-Endothelial-endothelial_cell_of_hepatic_sinusoid|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.01e-04 | 170 | 24 | 3 | 8fe32dcf924d5f6665f7febbc9647d96b1e96f06 | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal-Glutamatergic_Excit-Glut_A_(CT)-Glut_CT_L6_FEZF2-Exc_L6_FEZF2_CPZ|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.01e-04 | 170 | 24 | 3 | 021c3e45955d18e241f7d98acdf22076fee4fc43 | |
| ToppCell | droplet-Liver-LIVER_HEPATOCYTES-30m-Endothelial|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.01e-04 | 170 | 24 | 3 | 3232db50b1a40f861e981a1b9c9073b81af9f832 | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-vascular_smooth_muscle_cell-D088|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 1.08e-04 | 174 | 24 | 3 | 015d3742d3d79a57413a333f00ef2d380a9848dd | |
| Drug | chondroitin sulfate | 4.54e-06 | 413 | 25 | 6 | CID000024766 | |
| Disease | seborrheic dermatitis | 1.09e-04 | 20 | 23 | 2 | EFO_1000764 | |
| Disease | cytotoxicity measurement, response to clozapine | 2.33e-04 | 29 | 23 | 2 | EFO_0006952, GO_0097338 | |
| Disease | pancreatic ductal carcinoma (is_marker_for) | 1.03e-03 | 61 | 23 | 2 | DOID:3587 (is_marker_for) | |
| Disease | cholangiocarcinoma (is_marker_for) | 1.14e-03 | 64 | 23 | 2 | DOID:4947 (is_marker_for) | |
| Disease | small cell lung carcinoma | 1.77e-03 | 80 | 23 | 2 | EFO_0000702 | |
| Disease | vital capacity | 2.29e-03 | 1236 | 23 | 5 | EFO_0004312 | |
| Disease | pancreatic cancer (is_marker_for) | 2.80e-03 | 101 | 23 | 2 | DOID:1793 (is_marker_for) | |
| Disease | pancreatic cancer (is_implicated_in) | 3.43e-03 | 112 | 23 | 2 | DOID:1793 (is_implicated_in) | |
| Disease | renal cell carcinoma (is_marker_for) | 4.45e-03 | 128 | 23 | 2 | DOID:4450 (is_marker_for) |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| QWLEWGPWGPCSTSC | 421 | O60241 | |
| CPATDSKWGPWNAWS | 471 | O60241 | |
| PAPAWCPCGSCCSWW | 451 | Q9UMD9 | |
| PNGTQWLCSPNLWPW | 266 | P60509 | |
| NLWPWLPSGWLGCCT | 276 | P60509 | |
| VWGPWVQWASCSQPC | 46 | Q6UY14 | |
| CPVHGAWDEWSPWSL | 406 | O14514 | |
| WFQPPVCSNWGCWGG | 76 | Q8TC90 | |
| CCSCWSGSWNPGWVK | 121 | Q8TC90 | |
| ACPPRWWAGEWEACS | 881 | P58397 | |
| WWAGEWEACSATCGP | 886 | P58397 | |
| CWQNSWLPHGNSWVC | 1271 | Q68CQ1 | |
| WPSWGWNQVSCPCSW | 4571 | Q99102 | |
| WGWARQSWGQCQPVC | 46 | Q6UXI9 | |
| QAAPNGPAWCWWLLA | 721 | Q17RB8 | |
| SPPWSPAWICCWALA | 26 | A8MWY0 | |
| WSAWQPWGTCSESCG | 4646 | Q96RW7 | |
| GGWSCWSSWSPCVQG | 501 | P10643 | |
| LCWWWGLLCSCCGPP | 11 | P22004 | |
| VEWTGRWNDNCPSWN | 291 | P17655 | |
| WNSIPSCWALPWLNV | 271 | Q8NAC3 | |
| AACPVDGEWSTWSPW | 1746 | A2VEC9 | |
| CGWSSWSPWAKCLGP | 1911 | A2VEC9 | |
| PCGWSAWSSWAPCDR | 2716 | A2VEC9 | |
| SSWPCAEGEPTWSPW | 3176 | A2VEC9 | |
| GWCPWSEWTMCSQPC | 3411 | A2VEC9 | |
| AGNCSWTSWAPWEPC | 3946 | A2VEC9 | |
| DSCQWSLWGPWSPCQ | 4616 | A2VEC9 | |
| GQAWWWASQNPGHCP | 361 | A6NFQ2 | |
| NCSRNGGWTPWTSWS | 591 | Q13591 | |
| WTGWGPWERCTAQCG | 656 | Q13591 | |
| LPCPVDGVWSCWSPW | 836 | Q13591 | |
| RCWPSDSADDGWSPW | 371 | P07996 | |
| PLNCSSWWPAIQCCS | 456 | Q92599 | |
| ASCSSPVNWACPWCN | 951 | A0A0J9YWL9 | |
| TQACPEGWSPWSEWS | 961 | Q9P283 | |
| NGGWSSWAEWSPCSN | 246 | Q8IZJ1 |